BAX Baxter International Inc The healthcare-products provider reported third-quarter net income rose 19% on 16% higher sales and raised its earnings outlook for the full year. 59.07 +0.49 / +0.84%
BAX Baxter International Inc The Celvapan swine flu vaccine maker reported third-quarter adjusted sales that missed analysts' estimates. 54.89 -2.11 / -3.70%
__________________
All my posts are purely my opinion. Please use your own buy and sell signals and never invest in a stock you can not afford to lose money on. For a complete disclaimer click here